Johnson & Johnson

NYSE:JNJ   3:59:58 PM EDT
157.08
-1.00 (-0.63%)
4:56:39 PM EDT: $157.31 +0.23 (+0.15%)
Earnings Announcements

Health Canada Announces Results Of Emergent Biosolutions Facility Inspection

Published: 11/24/2021 17:22 GMT
Johnson & Johnson (JNJ) - :health Canada Announces Results of Emergent Biosolutions Facility Inspection.
Health Canada - All Three Regulators Found Facility to Be Compliant With Good Manufacturing Practices.
Health Canada - European Medicines Agency and South African Health Products Regulatory Authority Also Participated in This Inspection Remotely.
Health Canada - Compliant Rating Means Janssen to Be Able to Import Their Vaccines Into Canada Made With Drug Substance Manufactured at Emergent's Facility.
Revenue is expected to be $25.23 Billion
Adjusted EPS is expected to be $2.16

Next Quarter Revenue Guidance is expected to be $23.68 Billion
Next Quarter EPS Guidance is expected to be $2.61

More details on our Analysts Page.